Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (91-100 of 336) with videos related to

Pageof 34
Sort By:
The Breast Journal|May 12, 2001
Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer PatientsKalliopi P. Siziopikou, Stuart J. Schnitt, James L. Connolly, et al.
Nature Reviews. Cancer|October 13, 2006
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsVered Stearns, Bryan Schneider, N Lynn Henry, et al.
The American Journal of Psychiatry|October 3, 2008
Drug interactions and pharmacogenomics in the treatment of breast cancer and depressionN Lynn Henry, Vered Stearns, David A Flockhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancerJames M Rae, Meredith Regan, Brian Leyland-Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?Michaela J Higgins, James M Rae, David A Flockhart, et al.
Breast Cancer Research : BCR|November 24, 2007
International Web-based consultation on priorities for translational breast cancer researchMitch Dowsett, Aron Goldhirsch, Daniel F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583Susan Halabi, Eric J Small, Daniel F Hayes, et al.
Journal of the National Cancer Institute|May 18, 2021
Response to Zhang and YangTorsten O Nielsen, Samuel C Y Leung, Lisa M McShane, et al.
The Breast Journal|March 11, 2004
Tamoxifen-induced radiation recall dermatitisEric A Singer, Robert D Warren, Marie F Pennanen, et al.
The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.
Pageof 34

Showing results (91-100 of 336) with videos related to

Sort By:
Pageof 34
The Breast Journal|May 12, 2001
Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer PatientsKalliopi P. Siziopikou, Stuart J. Schnitt, James L. Connolly, et al.
Nature Reviews. Cancer|October 13, 2006
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsVered Stearns, Bryan Schneider, N Lynn Henry, et al.
The American Journal of Psychiatry|October 3, 2008
Drug interactions and pharmacogenomics in the treatment of breast cancer and depressionN Lynn Henry, Vered Stearns, David A Flockhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancerJames M Rae, Meredith Regan, Brian Leyland-Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?Michaela J Higgins, James M Rae, David A Flockhart, et al.
Breast Cancer Research : BCR|November 24, 2007
International Web-based consultation on priorities for translational breast cancer researchMitch Dowsett, Aron Goldhirsch, Daniel F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583Susan Halabi, Eric J Small, Daniel F Hayes, et al.
Journal of the National Cancer Institute|May 18, 2021
Response to Zhang and YangTorsten O Nielsen, Samuel C Y Leung, Lisa M McShane, et al.
The Breast Journal|March 11, 2004
Tamoxifen-induced radiation recall dermatitisEric A Singer, Robert D Warren, Marie F Pennanen, et al.
The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.
Pageof 34